On December 5, 2025, Vietnam Report Joint Stock Company (Vietnam Report) officially announced the Top 10 Reputable Pharmaceutical Manufacturing Companies in Vietnam for 2025. HATAPHAR is honored to be featured in this ranking, marking the 9th year the company has maintained its position in this prestigious list.
The “Top 10 Reputable Pharmaceutical Companies” ranking is a highly regarded annual study built on scientific and objective principles. Enterprises are evaluated comprehensively and transparently based on three primary criteria:
- Financial Capacity: Evaluated based on the latest financial statements, reflecting the business’s overall health and potential.
- Media Reputation: Assessed using the Media Coding method, which encodes articles about the company on influential media channels to measure brand awareness and public image.
- Stakeholder Surveys: Gathering feedback from experts, pharmacists, doctors, and consumers regarding product quality and brand trust, conducted between October and November 2025.
Being recognized for the 9th time in this prestigious ranking is a well-deserved acknowledgment of the tireless efforts of the Hatay Pharmaceutical team. It serves as clear evidence of a sustainable development strategy and a steadfast commitment to prioritizing product quality and consumer health—a path the company has pursued throughout its journey of growth.
This achievement not only affirms a brand reputation built and strengthened over decades but also reinforces the trust of our valued Customers, Partners, and industry experts. It is a source of immense pride and a powerful motivation for all employees to continue dedicating themselves to innovation and creativity, stepping firmly on the journey for community health.
HATAPHAR would like to express our sincere gratitude for your trust and companionship. We remain committed to providing high-quality products, contributing to the healthcare mission of the Vietnamese people.
